Anticipatory Medications for End of Life Patients Doses must be proportional to the current analgesic medication

Similar documents
END OF LIFE MEDICINES INFORMATION PACK

Community Pharmacists in NHS Rotherham

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Guidelines for the Use of Subcutaneous Medications in Palliative Care

Examples of Good Practice Resource Guide

Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013

Guide to the Pharmacological Management of End of Life (Terminal) Symptoms in Residential Aged Care Residents

Pain management. The WHO analgesic ladder

Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme

Symptom Control and Caring for the Dying Patient: Palliative Care Guidelines 4th Edition

WITHDRAWAL OF ANALGESIA AND SEDATION

Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol

Southlake Psychiatry. Suboxone Contract

A Guide to pain relief medicines For patients receiving Palliative Care

How To Take A Strong Opioid Painkiller

Local Enhanced Service Contract Supply Nene CCG of Drugs for use in Palliative Care by Community Pharmacies in Nene CCG and Corby CCG

Implementing stock end-of-life medication in UK nursing homes. Kathy Morris, Jo Hockley

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

Subcutaneous Medications and Palliative Care: A guide for caregivers

Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal

Guidelines for the use of Methadone for Adults with Pain in Palliative Care

Review of Pharmacological Pain Management

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

First published in 2006 as Guidelines for syringe driver management in palliative care. Reprinted 2007

Clinical protocol for the use of syringe drivers in palliative care patients (adults)

Palliative Care Integrated Clinical Pathway

Lanarkshire Palliative Care. Guidelines

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Objectives. Mechanism-Based Therapy. The Approach to Nausea, Vomiting, and Pain at The End of Life

Pain is a symptom people associate with a malignant illness and is common in non malignant disease.

Strong opioids (painkillers) in palliative care what you should know

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

SWL Supportive and Palliative Care Group and SWL Cardiac Network. Symptom Control Guidelines and key information in end-stage heart failure

OPIOIDS CONVERSION GUIDELINES 2007

Yorkshire Cancer Network. North East Yorkshire and Humber Clinical Alliance

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

Lidocaine Infusion for Perioperative Pain Management. Marley Linder, PharmD Matt McEvoy, MD

COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE

Standard Operating Procedure

Acute management of Parkinson s

DISTRIBUTION: All Clinical Units JHCH, J1, J2, H1, Oncology Day Stay Unit & J2 Day Stay Unit. JHH Intensive Care Unit and Emergency Department

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach

HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida

MEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

Nurses Self Paced Learning Module on Pain Management

Naloxone treatment of opioid overdose

Opioid Conversion Ratios - Guide to Practice 2013

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Opioid Conversion Ratios - Guide to Practice 2010

Downers/Depressants (pages 40-50)

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

WITHDRAWAL OF DRUG(S) OF DEPENDENCE

Methadone treatment Information for service users Page

Abstral Prescriber and Pharmacist Guide

PAIN & SYMPTOM CONTROL GUIDELINES

Opioid toxicity and alternative opioids. Palliative care fixed resource session

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline

Crisis Management in Hospice Patients

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less)

Drugs & Everything Else

D( desired ) Q( quantity) X ( amount ) H( have)

WORCESTERSHIRE MENTAL HEALTH PARTNERSHIP NHS TRUST GUIDELINES FOR THE MANAGEMENT OF ADULT OPIATE DEPENDENT PATIENTS IN THE ACUTE HOSPITAL SETTING

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!

Clinical Practice Guidelines: Nurse Practitioner, Palliative Care Service

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

Opioids in Palliative Care- Patient Information Manual

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT

Pharmaceutical care of people requiring palliative care Course activities

Rapid Opioid Detoxification - Guidelines

MODERATE SEDATION RECORD (formerly termed Conscious Sedation)

Pain Medication Taper Regimen Time frame to taper off days

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

Management of Constipation in Adults

Narcotic drugs used for pain treatment Version 4.3

Anticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

Hospice & Palliative Care in Developing Countries

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

Should Antihistamines be Used to Treat Anaphylaxis?

Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?

Policy for the issue of permits to prescribe Schedule 8 poisons

Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation

North of England Cancer Network. Palliative and end of life care guidelines for cancer and non-cancer patients

Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015**

Overdose Response Training

UNIT VIII NARCOTIC ANALGESIA

Naloxone Hydrochloride Injection PRODUCT INFORMATION

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

Gerald A Amundsen II, MD Mustang, Oklahoma

Opioid Analgesics. Week 19

MUSC Opioid Analgesic Comparison Chart

Transcription:

Anticipatory Medications for End of Life Patients Doses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients on Fentanyl should continue patch in addition to following guidelines. Please do not stop opiates in patients who are taking them regularly. PAIN Patient has pain which is not controlled Patient has no pain or pain is well controlled Is patient already taking oral morphine? Is patient already taking oral morphine? YES NO YES NO Convert to SC by dividing the total 24 hr dose of morphine by 3. As pain is not controlled the calculated dose od should be increased by 1/3 rd and administered via SC syringe driver over 24hrs. See palliative care guidelines and syringe driver policy. If this is ineffective contact the Specialist Palliative Care Team for advice. 2.5mg 5mg SC and prescribe this to be used PRN 1-2hrly 2) Start 5-10mg of /24hrs in a syringe driver 3) After 24 hrs review medication and, if the patient has needed breakthrough doses, increase the in the syringe driver proportional to the PRN diamorphine administered in past 24 hours Convert to SC by dividing total 24 hour dose oral Morphine by 3 e.g. Zomorph 30mg bd = 60mg morphine/24 hrs = 20mg Diamorphine/24 hrs via SC syringe driver SC 1-2 hrly which should be equivalent to 1/6 of 24hr dose in syringe driver (e.g. 30mg /24hrs SC via syringe driver will require 5mg SC 2-4 hrly PRN) 2.5mg-5mg SC 1-2hrly 2) After 24hrs review medication and, if two or more doses required PRN, then start syringe driver of 5-10mg / 24hrs To convert from other strong opioids contact the Palliative Care Team or Pharmacy for advice. Palliative Care Team Mon-Fri 9-5 Ext 3227 Dr. Nicola Holtom/ Palliative Care Team Page 1 of 5 Review date: October 2017

Doses must be proportional to the current benzodiazepine medication TERMINAL RESTLESSNESS AND AGITATION MIDAZOLAM 2.5 5mg SC and prescribe this to be used 1-2 hrly PRN. MIDAZOLAM 2.5 5mg SC 1-2 hrly 2) Start a syringe driver of MIDAZOLAM 5-10mg/24 hrs 3) Review the required medication after 24hrs and if the patient has needed breakthrough doses, then increase the MIDAZOLAM in the syringe driver to incorporate the additional amount required over the last 24hrs. 2) If two or more doses required PRN start syringe driver over 24hrs 10mg MIDAZOLAM/ 24 hrs 4) Continue to give PRN doses accordingly. Dr. Nicola Holtom/ Palliative Care Team Page 2 of 5 Review date: October 2017

Doses must be proportional to the current anti-secretory medication RESPIRATORY TRACT SECRETIONS 20mg SC 2) Start HYOSCINE BUTYLBROMIDE 80mg in a syringe driver SC/24 hrs 3) Continue to give 20mg SC 2-4hrly if needed 1) Prescribe HYOSCINE BUTYLBROMIDE 20mg SC 2-4hrly PRN 2) If two or more doses of PRN required, then start a syringe driver with 80mg SC/24hrs 4) Increase total 24hr dose to incorporate the additional amount administered during the past 24hours if symptoms persist Avoid using Hyoscine in patients with severe cardiac failure this can increase arrhythmias. Suggest using Glycopyronium Bromide 200 micrograms stat and 600micrograms/24 hours via syringe driver Dr. Nicola Holtom/ Palliative Care Team Page 3 of 5 Review date: October 2017

Doses must be proportional to the current anti-emetic medication NAUSEA AND VOMITING 6.25mg 2) Start syringe driver with 12.5-25 mg/ 24 hrs SC 3) Prescribe PRN dose of 6.25-12.5mg SC 2-4 hrly 4) Review dose after 24hrs. If the patient is still nauseated/vomiting or has required breakthrough doses, then increase the dose of accordingly in the syringe driver to a maximum of 37.5mg IN 24 hours. If this nausea/vomiting not controlled seek specialist advice 1) Prescribe 6.25-12.5mg SC 2-4 hourly PRN 2) Review after 24 hours if 2 or more doses administered please start syringe driver of 12.5-25mg /24hrs SC Alternative Anti-emetics CYCLIZINE 50mg SC PRN (100-150mg /24hr sc via syringe driver). Always use water for injections as diluent. Not compatible with Hyoscine Butylbromide or higher doses of Oxycodone; not recommended in patients with heart failure. METOCLOPRAMIDE 10mg SC PRN (30-60 mg SC/24hrs via syringe driver ) Avoid in complete bowel obstruction; the prokinetic effect of Metoclopramide will be blocked with antimuscarinic drugs such as Hyoscine Dr. Nicola Holtom/ Palliative Care Team Page 4 of 5 Review date: October 2017

Doses must be proportional according to current opiate/ benzodiazepine medication DYSPNOEA (Breathlessness) Is patient taking oral MORPHINE for breathlessness? 2.5mg- 5mg SC PRN 1-2 hrly Yes No 1) Convert to SC via a syringe driver (divide 24hr oral Morphine dose by 3 to calculate 24hr SC Diamorphine dose) Increase this calculated 24hr dose by 1/3 rd to alleviate breathlessness 1) Give a stat dose 2.5mg- 5mg SC 2) Start syringe driver 5-10mg/24 hrs 3) Prescribe 2.5-5 mg 1-2 hrly PRN for breakthrough breathlessness 2) Prescribe for breakthrough control of breathlessness (1/6 th of the total 24 hr Diamorphine dose) Information If patient is breathless and anxious/agitated consider the use of MIDAZOLAM 2.5mg SC stat or 5-10mg/24 hrs via syringe driver. Anticipatory prescribing in this manner will ensure that there will be no delay in responding to a symptom in the last hours/days of life. Dr. Nicola Holtom/ Palliative Care Team Page 5 of 5 Review date: October 2017